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Abstract.  On platelets the membrane glycoprotein 
lib/Ilia complex (GPIIb/IIIa) functions in adhesive in- 
teractions with fibrinogen, von Willebrand factor, and 
fibronectin. However, the function of GPIIb/IIIa-like 
proteins on endothelial cells, as well as the ligand(s) 
the complex binds,  is unknown.  Using a highly 
specific polyclonal antibody we have explored the 
function of GPIIb/IIIa-like proteins on human umbili- 
cal vein endothelial cells (HUVE).  Analysis by immu- 
noblotting shows that this antiserum recognizes the en- 
dothelial GPIIIa-like protein of the complex.  The IgG 
fraction of the polyclonai antiserum and its Fab' frag- 
ments detach confluent and subconfluent HUVE from 
extracellular substrata. The effect of the anti-GPIIb/ 
Ilia IgG is not toxic as the detached ceils maintain 
their viability after trypsinization and replating. 
Anti-GPIIb/IIIa IgG does not inhibit HUVE binding 
to extracellular matrix or purified fibronectin in an at- 
tachment assay despite the presence of intact GPIIb/ 
Ilia on HUVE detached from substrate by various 
methods. Apparently, the GPIIb/IIIa-like protein on 
HUVE is important in normal HUVE adhesion to the 
extracellular matrix, but it is not required in the initial 
attachment of HUVE to extracellular matrix. 
HESION of platelets to sites of vascular injury is one 
of the initial events ofhemostasis and thrombosis. The 
membrane  glycoprotein lib/Ilia  complex  (GPIIb/ 
Ilia) ~  on platelets has been shown to be a common binding 
site for several  ligands (Plow et ai.,  1984): fibrinogen (Ben- 
net et al.,  1982; Nachman and Leung,  1982; Pytela et al., 
1986), von Willebrand factor (DeMarco et al.,  1986; Fuji- 
moto and Hawiger,  1982; Nokes et al.,  1984), fibronectin 
(Gardner and Hynes, 1985; Plow and Ginsberg, 1981; Pytela 
et al.,  1986), and vitronectin (Pytela et al.,  1986). This set 
of interactions is at least partly responsible for platelet adhe- 
sion to the exposed subendothelium and growth of the hemo- 
static plug by aggregation of platelets with fibrin at the wound 
site  (Eldor  et  al.,  1985; Peerschke,  1985). Several  other 
receptors for extracellular matrix molecules have been de- 
scribed for cells, including the fibronectin receptor (Pytela 
et al.,  1985a) and the vitronectin receptor (Pytela et al., 
1985b).  Like these cytoadhesive proteins, GPIIb/IIIa binds 
to peptides containing Arg-Gly-Asp sequence, the cell at- 
tachment site of fibronectin (Pierschbacher and Ruoslahti, 
1984).  Similar Arg-Gly-Asp  sequences  are  also  found in 
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fibrinogen (Doolittle et al., 1979; Gartner and Bennett, 1985) 
and vitronectin (Suzuki et al., 1985), suggesting that platelet 
GPIIb/IIIa (Gartner  and  Bennett,  1985; Ginsberg  et  al., 
1985), the fibronectin receptor, and the vitronectin receptor 
belong to a family of proteins responsible for attachment of 
a variety of cells, not just platelets (Pytela et al.,  1986). 
Human umbilical vein endothelial cells (HUVE) and bo- 
vine aortic endothelial cells (BAE) have recently been shown 
to synthesize a plasma membrane protein complex immuno- 
logically related to the platelet GPIIb/IIIa complex (Thiaga- 
rajan et al.,  1985; Fitzgerald et al.,  1985; Leeksma et al., 
1986; Newman et al., 1986). The GPIIb/IIIa complex exists 
in endothelial cells as a noncovalent heterodimer composed 
of a subunit of GPIIb with mol wt 135,000 and a subunit of 
GPIIIa with mol wt 105,000 (Fitzgerald et al., 1985; Leeks- 
ma et al,, 1986). The experiments reported here were under- 
taken to determine whether GPIIb/IIIa had an adhesive func- 
tion for the endothelium. Our data suggest that GPIIb/IIIa is 
involved in the normal adherence of HUVE to extracellular 
matrix, but not the initial attachment of the cell to matrix as 
determined in a cell attachment assay. 
Materials and Methods 
Culture of  Endothelial Cells 
HUVE were isolated as previously described (Gimbrone, 1976) and grown 
in medium consisting of RPMI-1640  containing l0 mM Hepes, 20%  fetal 
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cell growth factor (Maciag et al., 1979) and 90 p,g/ml heparin (Sigma Chem- 
ical Co., St. Louis, MO) (Thornton et al., 1983) in gelatin-coated tissue cul- 
ture fasks (Corning Glass Works, Corning, NY). These cells were used be- 
tween passages 1 and 3 and stained positively for von Willebrand factor by 
indirect immunofluorescence. BAE were isolated and cultured as previously 
described (Gajdusek and Schwartz, 1983). 
Antibodies 
Rabbit anti-human platelet glycoprotein IIIa antiserum was prepared as pre- 
viously described (Thiagarajan et al., 1985). Briefly, human platelet GPIIb/ 
IIIa was isolated by immunoafflnity chromatography and separated by SDS- 
PAGE. The band corresponding to GP IIIa was cut out of the gel and the 
protein eluted and injected to rabbits.  The IgG fraction was purified by 
affinity chromatography on a protein A-agarose column (BioRad Laborato- 
ries,  Richmond, CA) according to the manufacturer's procedure. F(ab32 
fragments were prepared by pepsin digestion followed by removal of intact 
IgG  and  Fc  fragments by protein A-Sepharose as described previously 
(Nisonoff et al., 1960). The F(ab')2 was converted to Fab' as described pre- 
viously (Brackenbury et al.,  1977). Analysis by SDS gel electrophoresis 
showed that the reduction was complete and only Fab  was present (data not 
shown). Anti-GPIIb/IIIa IgG and the control IgG were labeled with 125I by 
the Iodogen method (Markwell et al.,  1978) to a specific activity of 8.4  ￿ 
105 and 3.25  x  105 cpm/Ixg,  respectively. The IgG fraction of rabbit anti- 
human 1~2-microglobulin and rabbit anti-bovine fibronectin (Calbiochem- 
Behring Diagnostics, San Diego, CA) were also purified by adsorption to 
protein A-agarose column (BioRad Laboratories). The reactivity of anti-132- 
microglobulin IgG on HUVE was confirmed by ELISA assay. Anti-GPIIb/ 
IIIa  IgG,  anti-GPIlb/IIIa  Fab'  fragments,  eSI-anti-GPIIb/IIIa  IgG, 
anti-132-microglobulin, anti-bovine fibronectin, and nonimmune rabbit IgG 
(Calbiochem Behring Diagnostics) were dialyzed overnight at 4~  against 
Dulbecco's phosphate-buffered saline (PBS)  and  filtered through  Millex 
0.22-I.tm pore GV filters (Millipore Corp, Bedford, MA) before use. A mu- 
fine monoclonal antibody (mAb 60.5) directed against a framework class 
I MHC antigen was a kind gift from Dr. John Hansen of the Fred Hutchin- 
son Cancer Research Center, Seattle, WA. Protein concentrations were de- 
termined as described previously (Bradford, 1976) using bovine serum albu- 
min as a standard. 
Cell Detachment Assay 
HUVE (7.5  x  104) were plated in a gelatin-coated, 48-well plate (Costar, 
Cambridge, MA) in 0.5 ml of complete medium per well containing 1 IJl2i 
[35S]methionine  (Dupont New England Nuclear Research Products, Bos- 
ton, MA; specific activity,  1,255 Ci/mmol) and grown to confluence for 2 d. 
Anti-GPIIb/IIIa IgG, anti-GPIIb/HIa Fab' fragments, or control antibodies 
were added 2 d after plating. The radioactivity of adherent cells was deter- 
mined 2.5 d after the addition of the antibody. The wells were washed three 
times with PBS to remove nonadherent cells and the remaining cells were 
solubilized with 0.3 ml of 1% SDS per well for 0.5 h at 37~  The solubilized 
samples were transferred to scintillation vials with 5 mi Aquasol (Dupont 
New England Nuclear Research Products) and counted in a liquid scintilla- 
tion counter. The percentage of adherent cells at the end of the assay was 
determined as the counts per minute in the test well divided by the counts 
per minute of control (untested) well. 
Time lapse videography of cell detachment was performed using Hoff- 
man modulation phase-contrast optics and analogue video image enhance- 
ment as previously described (Hansson et al., 1985). For these experiments 
cells were maintained at 37~  in a sealed Lab-Tek flaskette (Miles Scientifc, 
Naperville, IL). 
Cell Attachment Assay 
Extracellular matrix was prepared as described previously (Gospodarowicz 
et al.,  1981) from BAE which were confluent for 2 wk in a 24-well plate. 
Fibronectin substratum was prepared as described previously (Harper 
and  Juliano,  1980) with  some modifications. Briefly,  0.5  ml  of bovine 
fibronectin (Sigma Chemical Co.) at 20 I.tg/ml of PBS was added to each 
well and the 24-well plate was incubated for 2 h at 37~  Then 0.5 ml of 
1% bovine serum albumin, which had been denatured at 80~  for 3 min, 
was added and the plate was incubated for another hour at 37~  The wells 
were then washed thoroughly with PBS to remove any nonadsorbed protein. 
Waymouth's  medium +  10 mM Hepes, ph 7.4 (1 ml/well) was added and 
the wells were ready for use in the adhesion assay. 
The cell substratum attachment assay was based on that by Brown and 
Juliano, 1985. HUVE (8 x  105) labeled with 2 p.Ci [3SS]methionine per ml 
of medium (4 ml total for a 25-cm  2 flask)  for 2 d  were trypsinized with 
0.1 mg/ml of trypsin (Cooper Biomedical, Malvern, PA; 189 U/mg protein) 
in Ca2+/Mg2+-free PBS containing 1 mM CaCI2. After centrifugation they 
were aliquoted in Waymouth's  medium containing 10 mM Hepes, pH 7.4 + 
0.1% bovine serum albumin at 3  x  104 cells per 100 ~tl. The cells were in- 
cubated with appropriate antibodies at 4~  for 0.5 h before the attachment 
assay. Cells were then plated into the coated wells in 1 ml of Waymouth's 
medium. At the end of the incubation at 37~  (1.5 or 6 h), the wells were 
washed three times with PBS. The remaining cells in each well were solubi- 
lized and counted in a liquid scintillation counter (Packard Instrument Co., 
Downers Grove, IL). The total counts per minute of cells plated was taken 
as the counts per minute of adherent and nonadherent cells of the control 
wells (no antibody added). The percentage of cells attached was determined 
as the counts per minute in each well divided by the counts per minute of 
the total  cells plated. 
Binding of 12JI-labeled Antibodies to HUVE 
The binding of t~I-labeled antibodies to HUVE were studied both in mono- 
layers and in suspension. Confluent monolayers of HUVE were grown in 
24-well tissue culture plates and the medium was changed to Waymouth's 
medium containing 10 mM Hepes, pH 7.4 before incubation with antibod- 
ies. Various concentration of 125I-labeled antibodies were incubated with 
the monolayers for 30 rain at 4~  in a total volume of 0.5 ml per well. After 
incubation the supernatant medium was aspirated and the monolayers were 
washed two times. The washed cells in each well were solubilized in 0.3 
ml of 1% SDS and counted in a gamma counter (Beckman Instruments Inc., 
Fullerton, CA). Nonspecific binding was determined by measuring residual 
binding of the labeled antibodies in the presence of 50-fold excess of unla- 
beled antibody. 
For binding studies in suspension, HUVE were grown to confluence in 
25-cm  2 flasks over 4 d. Cells were detached by incubation for: (a)  10 min 
at 37~  in 4 ml of 0.1 mg/ml trypsin (Cooper Biomedical) containing 1 mM 
CaC12 in Ca  2+ and Mg2+-free PBS, followed by an equal volume of 1 mg/ml 
soybean trypsin inhibitor (SBTI) (Cooper Biomedical); (b) 30 min at 37~ 
in 4 ml of 0.1 mg/ml collagenase (Worthington Diagnostics Inc., Freehold, 
NJ; 125 U/mg CLS II) in PBS, followed by an equal volume of 0.1% SBTI; 
(c)  10 min at 37~  in 4 ml 0.5 mM EDTA in Ca  2+ and Mg2§  PBS and 
then pipetted vigorously (Rosen and Culp, 1977); (d) 4-5 h at 37~  in 4 mM 
Arg-Gly-Asp-Ser (RGDS) (Peninsula Laboratories, Belmont, CA) in 4.6 ml 
of Waymouth's  medium +  10 mM Hepes, pH 7.4. 
The detached cells were counted and incubated with ~25I-labeled anti- 
bodies at 4~  for 0.5 h in 100 ~tl Waymouth's medium containing 10 mM 
Hepes and 0.1% bovine serum albumin. After incubation, the cells were 
washed twice by centrifugation at 1,000 rpm for 10 min in 5 ml of PBS con- 
taining 10 mM KI followed by centrifugation in a microfuge for 2 min. The 
supernatant medium was aspirated and the remaining cells were solubilized 
with  1%  SDS  for counting in a  gamma counter (Beckman Instruments, 
Inc.). "Nonspeciflc" binding was measured with 100-fold excess of the ap- 
propriate unlabeled antibody incubation and subtracted from the total bound 
to give "specific"  binding. 
Electrophoresis  and lmmunoblotting 
Pellets of cells (4  x  106) detached by the methods described above were 
suspended in a lysis buffer containing 0.5% (wt/vol) Nonidet P-40, 0.1 M 
NaCI,  0.02  M  Tris,  pH 7.5, 0.1  mM phenylmethylsulfonyl fluoride,  100 
~tg/ml leupeptin, 10 mM N-ethylmaleimide, and 1 mM EDTA and incubated 
at 4~  for 15 min. The cell lysates were centrifuged at 10,000 g for 15 min 
at 4~  and the supernatants were subjected to SDS-PAGE (7.5 %) (Laemmli, 
1970). The separated proteins were electrophoretically transferred to nitro- 
cellulose paper 0.45  p.m (Schleicher & Schuell, Inc., Keene, NH) as de- 
scribed previously (Towbin  et al.,  1979). After transfer, the nitrocellulose 
paper was incubated in 3 %  bovine serum albumin and then with anti- 
GPIIb/IIIa IgG at  15  p.g/ml  for 2  h  at room temperature. The blot was 
washed five times in Tris-buffered saline (0.02  M  Tris-HCl and 0.15 M 
NaC1,  pH 7.5)  containing 0.05%  NP-40 and  alkaline pbospbatase con- 
jugated  anti-rabbit  IgG  was added (Promega Biotec,  Madison,  WI)  at 
1:5,000 for 1 h. After washing, the paper was developed in bromo-chloro- 
indolyl-phosphate/nitro-blue-tetrazolium  substrate for 10 min (Leary et al., 
1983). The following proteins were used to calculate the apparent molecular 
weights: chicken muscle myosin heavy chain (200,000),  13-galactosidase 
(116,000), pbosphorylase b (94,000),  bovine serum albumin (67,000),  and 
ovalbumin (43,000). 
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IgG with platelets. Platelets solubilized in 
0.5 % NP40 were run on SDS-PAGE  under 
nonreducing  and  reducing  conditions. 
The gel was transferred to nitrocellulose 
paper, incubated with respective antibod- 
ies, washed, and developed with goat an- 
ti-rabbit horseradish peroxidase. Lane 1, 
anti-GPIIb/IIIa  IgG, nonreduced; lane 2, 
anti-GPIIb/IIIa  IgG, reduced. This shift 
in mobility upon reduction is characteris- 
tic of GPIIb and GPIIIa. 
Results 
Specificity of  Anti-GPIlb/llIa IgG 
A  polyclonal antibody was  prepared which reacts  specifi- 
cally with the GPIIIa subunit of the GPIIb/IIIa complex in 
human platelets and endothelial cells as demonstrated by im- 
munoblotting (Fig.  1 and Fig.  8). The GPIIb/Ma complex 
was  immunoprecipitated  from  t25I-surface labeled  HUVE 
with the anti-GPIIb/IIIa antibody (data not shown),  simi- 
lar to results described by others (Fitzgerald et al.,  1985; 
Leeksma et al.,  1986;  Newman et al.,  1986).  Additionally, 
with  platelet  sample  the  polyclonal antibody  cross-reacts 
with GPIIb (Fig.  1). The 60-kD band detected on immuno- 
blot (Fig. 1 and Fig. 8 B) may represent proteolytic  cleavage. 
In addition, occasional nonspecific reactivity with this band 
was also seen with nonimmune rabbit IgG (data not shown). 
When nonimmune rabbit IgG was substituted it showed no 
reactivity with either platelet or endothelial GPIlb or GPIIIa 
(data not shown). 
Detachment of  HUVE by Anti-GPIlb/IIIa IgG 
The effect of polyclonal anti-GPIIb/IIIa antibody on conflu- 
ent HUVE was studied using a time-lapse video image mi- 
croscopy. Photomicrographs taken at appropriate time inter- 
vals are shown in Fig. 2. Within 1 h of anti-GPIIb/IIIa IgG 
incubation, the cells seemed more active and motile with fre- 
quent wavy movements occurring between cells. No disrup- 
tion of the monolayer could be identified until after 6 h  in 
the presence of anti-GPIIb/IIIa IgG. Areas of detachment, 
or "holes; were noted usually around the perimeter of the 
monolayer at 4-12 h (Fig. 2 B). Characteristically, cells re- 
tained their cell-cell organization, detaching as sheets from 
the substratum rather than as individual cells. The detached 
cells were retracted and compressed along the hole with min- 
imal release of individual cells into the media (Fig.  2  C). 
With time more holes developed, enlarged,  and coalesced 
until sheets of cells were detached from the matrix as clumps 
of cell aggregates (Fig. 2 D). Anti-GPIIb/IIIa IgG added to 
confluent BAE monolayers also caused detachment, but it 
was  not as dramatic as detachment of HUVE monolayers 
with holes developing, but complete detachment of the mono- 
layer rarely occurring (data not shown). When the monolayer 
was exposed to anti-GPllb/Ma IgG for 0.5 h  at 37~  fol- 
lowed by removal of the antibody by gentle washing, detach- 
ment similar to that observed with continuous antibody still 
occurred 16-24 h after anti-GPIIb/Ma IgG addition. How- 
ever, incubation of the anti-GPIIb/Illa IgG for 15 min had 
minimal effect. The detachment time of both confluent and 
subconfluent (3  ￿  104 cell/cm  2) HUVE from the same iso- 
lation and passage in the presence of the antibody was identi- 
cal. The cells detached by anti-GPIIb/IIIa IgG were able to 
reattach and spread at 24 h on gelatin-coated glass slides af- 
ter treatment with trypsin to separate the detached sheets into 
single cells (Fig. 2 F). The cells detached by anti-GPIIb/Ma 
IgG were viable as demonstrated by their ability to attach and 
grow after trypsinization and replating. In addition, 90%  + 
3% of the detached cells versus 92%  +  2% of control cells 
excluded trypan blue. 
We next examined the effect of the concentration of anti- 
GPIIb/IIIa IgG on HUVE detachment.  The antibody was 
added to [35S]methionine-labeled HUVE and the percentage 
of adherent cells was determined 2.5 d after the addition of 
anti-GPIIb/IIIa IgG or nonimmune rabbit IgG. Detachment 
of cells was  concentration dependent as  shown in  Fig.  3. 
Half-maximal  detachment  occurred  with  50  l~g/ml  anti- 
GPIIb/IIIa IgG or with 50 gg/ml anti-GPIIb/IIIa Fab' frag- 
ments (Fig.  3). 
Nonimmune rabbit IgG was without effect on HUVE mono- 
layers over the same time course at similar concentrations as 
anti-GPIIb/Ma  IgG.  Anti-human  132-microglobulin  IgG, 
which is directed against class I MHC antigens on the cell 
surface of endothelial cells (Parham et al.,  1977; Messner, 
1984; Daar et al.,  1984; Goldstein et al.,  1985) did not dis- 
rupt the confluent monolayer even at a concentration of 1,000 
~tg/ml  IgG  over a  48-h  incubation.  Monoclonal antibody 
60.5, directed to a framework class I MHC antigen, was also 
without effect. 
The time course of detachment varied with different sub- 
strates.  Time-lapse video microscopy of HUVE grown on 
gelatin-coated plastic plates  showed cell detachment with 
anti-GPIIb/IIIa IgG or anti-GPIIb/Ma Fab' fragments only 
after 36 h in the presence of the antibody. The basis for the 
different time course of cell detachment from gelatin-coated 
glass surfaces vs. gelatin-coated plastic surfaces is unclear. 
Detachment was not more rapid by using higher concentra- 
tions of antibody. It is possible that this difference is due to 
differences in adsorption of gelatin or serum proteins to the 
two substrates, or to differences in matrix production when 
cells are grown on the different surfaces. 
Because the platelet GPIIb/Ma complex interacts with ex- 
tracellular matrix proteins containing the sequence RGDS, 
we investigated the effect  of synthetic peptides containing this 
sequence on HUVE detachment. Cells detached completely 
from the substratum after 4-6 h of incubation with RGDS 
(4 mM) or GRGDSP (4 mM)  (Fig. 4).  A control peptide, 
GRGESP (Gly-Arg-Gly-Glu-Ser-Pro) (4 mM), did not dis- 
rupt the monolayer over the same incubation interval. After 
detachment by RGDS or GRGDSP and three washes with 50- 
fold volume of medium, HUVE were able to reattach and 
spread to extracellular matrix or fibronectin-coated dishes. 
Chen et al. Involvement of Glycoprotein-like  Protein  in Adhesion  1887 Figure 2. Effect of anti-GPfib/IIIa IgG on the morphology of HUVE monolayer.  HUVE (2  x  105 cells/cm  2) plated in two-chamber glass 
slides  were grown to confluence over 4 d and then treated  as follows:  (A) 50 p.g of nonimmune rabbit  IgG/ml at 36 h. (B) 50 txg of 
anti-GPIIb/IIIa  IgG/ml after 8 h of incubation  showing areas of cell detachment.  (C) 50 ~tg of anti-GPllb/IIIa IgG/ml after 12 h of incuba- 
tion showing cells compressed along enlarging hole.  (D) 50 p.g of anti-GPIIb/IIIa after 16 h of incubation  showing sheets of cells detached 
from matrix.  (E) Anti-GPIIb/IIIa IgG-detached ceils  resuspended  in medium after treatment with trypsin-EDTA.  (F) Anti-GPIIb/IIIa 
IgG-detached ceils 24 h after treatment with trypsin-EDTA and replating showing that most cells have reattached and spread.  Cell morphol- 
ogy was examined  and photographed using an Olympus inverted-phase  microscope. Bars,  20 ~tm. 
Effect of  Anti-GPIlb/IIIa on Initial Attachment 
of HUVE 
We adapted the substratum attachment assay of Brown and 
Juliano (1985) that measures the initial binding events. Cells 
from confluent cultures were removed and treated with anti- 
GPIIb/IIIa at 4~  The fraction of cells adhering to the sub- 
stratum reached a plateau after 1 h of incubation during a 6-h 
assay in serum-free condition (data not shown).  Regardless 
of the  method  used  to detach  HUVE,  preincubation  with 
anti-GPIIb/IIIa IgG did not inhibit attachment of HUVE to 
extracellular matrix at either 1.5 or 6 h when compared with 
attachment in the presence of nonimmune rabbit IgG (Fig. 
5).  Anti-GPIIb/IIIa IgG also did not inhibt HUVE attach- 
ment to bovine fibronectin-coated plastic. However, anti-bo- 
vine flbronectin IgG was able to inhibit HUVE attachment 
to  fibronectin-coated  plastic  nearly  90%  (Fig.  6).  Anti- 
GPIIb/IIIa  IgG did not inhibit RGDS- or GRGDSP-detached 
HUVE cells from reattaching to BAE extracellular matrix or 
fibronectin-coated dishes.  In contrast,  addition  of 0.1  mM 
RGDS to HUVE detached by trypsin-EDTA prevented cell 
reattachment  at 6  h  (Fig.  6).  SGDR (Ser-Gly-Asp-Arg), a 
control pcptide with an identical amino acid composition but 
reversed sequence,  had no effect on cell attachment at the 
same or fourfold higher concentration. 
Binding of 12Jl-labeled Anti-GPIIb/Illa lgG to HUVE 
t25I-labeled  anti-GPIIb/IIIa IgG bound to confluent mono- 
layer of HUVE with a  saturating  concentration of 8  Ixg/ml 
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Figure 3.  HUVE detachment by anti-GPIIb/IIIa. HUVE (7.5  ￿ 
104 per well; 48-well Costar plate) were grown to confluence in 0.5 
ml of medium containing  1.0 laCi of [35S]methionine. Percent  cell 
detachment was determined 2.5 d after addition  of antibody.  (o) 
rabbit IgG; (o) anti-GPIIb/IIIa IgG; (zx) 60.5; (A) anti-GPIIb/IIIa 
Fab'; (D) rabbit anti-human 1~2-microglobulin IgG. Values repre- 
sent the means of quadruplicate  determinations. 
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morphology of HUVE.  5  x  105 cells/25- 
cm  2 flasks were grown to confluence over 
3 d, rinsed twice with Waymouth's medium 
+  10 mM Hepes,  pH 7.4,  and incubated 
with 4 mM GRGDSP or 4 mM GRGESP in 
Waymouth's medium +  10 mM Hepes, pH 
7.4. (A) Cells incubated with 4 mM GRGESP 
for 6 h are still confluent.  (B) Ceils incu- 
bated  with 4  mM GRGDSP for 2 h show 
areas  of  cell  detachment  occurring.  (C) 
Cells incubated  with 4 mM GRGDSP for 
6 h show complete monolayer detachment. 
(D)  Cells detached  by GRGDSP followed 
by three washes with 50-fold volume of me- 
dium show reattachment  24 h after  replat- 
ing. Bars,  20 Ixm. 
(Fig. 7). At saturation, 3  x  105 molecules of IgG were bound 
per cell in monolayer culture. The number of binding sites 
is similar to that described by Thiagarajan et al., (1985)  by 
Scatchard analysis. In three separate experiments with differ- 
ent strains of HUVE,  1  x  105 to 6  x  105 molecules of IgG 
were bound per cell. 
Platelet surface glycoproteins Ib, IIb, and IIIa can be pro- 
teolyzed with incubation  of 0.1% trypsin for 30 min (Phillips, 
1972). Therefore, we determined the binding at saturation of 
lZSI-labeled  anti-GPIIb/IIIa IgG to  HUVE detached enzy- 
matically and nonenzymatically (Table I).  The amount of 
125I-labeled anti-GPIIb/IIIa IgG bound to HUVE detached 
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Figure 5.  Effect of anti-GPIIb/IIIa  on attachment  of HUVE. 25- 
cm  2 flasks of confluent HUVE labeled with [35S]methionine for 
2 d were detached  with 0.1  mg/ml trypsin +  1 mm CaC12. Ali- 
quots  of HUVE were preincubated with an indicated  amount of 
anti-GPIIb/IIIa  IgG (hatched bar) or rabbit IgG (open bar) at 4~ 
for 0.5 h before transferring to extracellular matrix-coated  wells. 
After 6 h of incubation at 37~  the wells were washed three times 
with PBS and then solubilized, and the percentage of attached cells 
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Figure  6.  Effect of RGDS and SGDR on attachment  of HUVE to 
extracellular  matrix-coated  wells.  Confluent HUVE were labeled 
with [35S]methionine  as in Fig. 5. Aliquots of cells were incubated 
with appropriate  antibodies or peptides  (rabbit IgG,  open  bar; 
anti-GPIIb/IIIa  IgG, hatched bar; rabbit anti-bovine fibronectin, 
open bar with vertical lines; RGDS, closed bar; or SGDR, dotted 
bar) at 4~  for 0.5 h before transferring to wells precoated with ex- 
tracellular matrix.  After 6 h of incubation at 37~  the percentage 
of attached cells was determined as in Fig. 5. Values represent the 
means +  1 SD of triplicate  wells. 
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Figure 7. t~I-labeled  anti--GPflb/I~a IgG binding of HUVE. HUVE 
were grown to confluence in a 48-well, gelatin-coated plate. Cells 
were then labeled with various concentration of ~25I-labeled anti- 
GPIIb/IIIa  IgG or J25I-labeled  nonimmune rabbit IgG in the pres- 
ence of 50-fold excess unlabeled IgG for 0.5 h at 4~  on a rotary 
shaker. The cells were then washed, solubilized with 1% SDS, and 
counted. The results have been adjusted to the same specific activ- 
ity. Values represent the means of triplicate wells. 
Figure 8. Reactivity of anti-GPIIb/IIIa  IgG with HUVE detached 
by various treatments. HUVE solubilized in 0.5 % NP40 were ana- 
lyzed on SDS-PAGE  under (A) nonreducing or (B) reducing condi- 
tions.  The gel was transferred  to nitrocellulose paper,  incubated 
with  anti-GPIIb/IIIa IgG,  washed,  and  then  incubated  with 
anti-rabbit IgG antibody conjugated with alkaline phosphatase. Ly- 
sates from 2  ￿  106 HUVE were  applied to each  lane.  Lane 1, 
scraped cells; lane 2, 0.1 mg/ml trypsin-detached cells; lane 3, 0.1 
mg/ml collagenase-detached cells; lane 4, 0.5 mM EDTA-detached 
cells;  lane 5, 4 mM RGDS-detached cells. 
by either trypsin or collagenase was similar to that bound to 
HUVE removed by mechanical scraping. 
Immunoblot Analysis of  Detached HUVE 
To  further  characterize the  GPIIIa-like protein  in  HUVE 
detachment by various methods, we analyzed the GPIIIa by 
SDS-PAGE and subsequent immunoblotting. The amount of 
GPIIIa was  similar in  HUVE detached  by trypsin,  colla- 
genase, EDTA, RGDS, and mechanical scraping. Reduction 
with 2-mercaptoethanol decreased antibody binding to simi- 
lar levels among cells detached by different methods (Fig. 8 
B). In our study, GPIIb/IIIa  on HUVE exhibited a molecular 
Table L Binding of l25l-labeled Anti-GPllb/llla IgG to 
HUVE Detached by Various Treatments 
25i_labele  d 
anti-GPIIb/Illa IgG 
Method of  Total  Nonspecific  ~251-nonimmune IgG: 
detachment  binding  binding  total binding 
cpm/lO  5 cells  cpm/lO  5 cells  cpm/lO  s cells 
Mechanically 
scraped  1,327  232  112 
0.01% trypsin  1,254  260  190 
0.01% collagenase  1,136  300  157 
0.5 mM EDTA  997  276  182 
4 mM RGDS  1,300  155  126 
Confluent HUVE of the same swain and passage were grown in 25-cm  2 flasks 
and then variously detached (see Materials and Methods). Cells were incubated 
with t2Sl-labeled  anti-GPllb/IIIa IgG (6.7  x  I(Y  i cpm/105 cells) at 40C for 0.5 
h.  Cells were  rinsed twice and  centrifuged at  1,000  rpm  for  10  min with 
50-fold excess of l0 mM KI in PBS followed by centrifugation in an Eppendorf 
microfuge. Residual media was aspirated and the cell pellet counted. "Nonspe- 
ciflc" binding was measured in the presence of 100-fold excess of unlabeled 
anti-GPIIb/IIIa IgG. For binding of t25I-labeled  nonimmune rabbit IgG, cells 
were  incubated  with  ~251-1abeled nonimmune  rabbit  IgG  at  2.60  ￿  106 
cpm/105 ceils at 4"C for 0.5 h  and processed as detailed above. Specific ac- 
tivities for 125I-labeled anti-GPIIb/IIIa IgG and 125I-labeled nonimmune rabbit 
IgG were 8.4  x  I05 and 3.25  x  105 cpm/Ixg, respectively. 
weight of 100,000 unreduced and  117,000 reduced.  The de- 
crease in mobility with reduction is characteristic of GPIIIa 
in platelets, BAE, and HUVE (Fitzgerald et al.,  1985; Leeks- 
ma et al.,  1986).  The amount of the 65-kD band appears to 
be independent of detachment condition. 
Discussion 
IgG prepared from a polyclonal antibody that reacts specif- 
ically with endothelial GPIIIa and its Fab' fragments cause 
HUVE to detach as a  connected sheet.  Nonimmune rabbit 
IgG and rabbit anti-human 132-microglobulin  IgG, which is 
directed against class I MHC surface antigen, did not cause 
cell detachment. The detached cells exclude trypan blue and 
reattach to extracellular matrix after trypsin treatment dem- 
onstrating that detachment by anti-GPIIb/IIIa  IgG is not due 
to cytotoxicity. The pattern of detachment as sheets of cells 
lifting off the matrix and the aggregation of detached cells 
into clumps implicates the GPIIb/IIIa complex in cell-ma- 
trix interaction as opposed to cell-cell interaction (Edelman, 
1983;  Grinnel,  1978). Cross-linking experiments show that 
platelet GPIIIa interacts  directly with the cell-binding do- 
main  of fibronectin containing  the  Arg-Gly-Asp sequence 
(Gardner and Hynes, 1985).  Unlike its counterpart on plate- 
lets, the formation of the GPIIb/IIIa  complex on endothelial 
cells does not seem to be Ca2+-dependent (Fitzgerald et al., 
1985).  The molecular weights of GPIlb/IIIa-like proteins in 
endothelial  cells  are  also  slightly  different  from platelets 
(Thiagarajan et al.,  1985;  Fitzgerald et al.,  1985;  Leeksma 
et al.,  1986).  In that platelet GPIIb/IIIa binds to molecules 
contained in the extracellular matrix, it is possible that HUVE 
detachment by anti-GPIlb/IIIa  IgG is due to disruption of in- 
teractions of GPIlb/IIIa complex with fibronectin, vitronec- 
tin, thrombospondin, or some other protein(s) located in the 
subendothelial matrix (Ruoslahti et al., 1985). This hypothe- 
sis,  however,  does  not  readily  explain the  time course of 
detachment.  The antibody requires several hours to detach 
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as 0.5-h pretreatment with the antibody. This observation, 
along with the similarity in the time course of detachment 
of confluent and subconfluent cells, argues against the possi- 
bility that the delay in detachment simply reflects the time 
required for the antibody to diffuse to the underside of the 
cell. The ability of the Fab' fragment to detach cells suggests 
that cross-linking of GPIIb/IIIa molecules on the cell surface 
is not involved in the detachment by anti-GPIIb/IIIa anti- 
body. The remaining possibility is that the antibody some- 
how alters the conformation or function of GPIIb/IIIa com- 
plex, perhaps by altering its distribution in the membrane, 
interaction of the GPIIb subunit with the GPIIIa subunit, or 
interaction of the GPIIb/IIIa complex with other membrane 
proteins. 
The possible involvement of the GPIIb/IIIa complex in the 
maintenance of endothelial cell shape or cell attachment is 
not totally unexpected. Fibrin (Kadish et al., 1979; Rowland 
et al., 1984; Schleef and Birdwell, 1984; Weimar and Delvos, 
1986) and collagen (Delvos et al., 1982) alter endothelial cell 
shape dramatically when added to the cell surface. The effect 
of these proteins is not simply due to low-affinity interaction 
of the cell surface with fibrillar structures since fibrin pep- 
tides have the same effect (Rowland et al.,  1984; Watanabe 
and Tanaka, 1983). Recently, DeJana et al. (1985) documented 
that fibrinogen binds to a receptor on the endothelial surface. 
It is not known whether endothelial GPIIb/IIIa function as 
a fibrinogen receptor as does platelet GPIIb/IIIa, or whether 
the mechanism by which fibrin peptides produce cell detach- 
ment is similar to that of anti-GPIIb/IIIa antibody. 
The effect of anti-GPIIb/IIIa antibody on GPIIb/IIIa dif- 
fers from the effect of antibodies to other cellular receptors 
for attachment proteins. Polyclonal and monoclonal antibod- 
ies against plasma membrane glycoproteins involved in cell- 
substratum adhesion, i.e., anti-FN receptor antibody in Chi- 
nese hamster ovary fibroblast (Brown and Juliano,  1985), 
anti-cell-substrate attachment antigen (CSAT) receptor anti- 
body in chicken embryo myogenic fibroblast cells (Damsky 
et al., 1985; Greve and Gottlieb, 1982; Knudsen et al., 1981; 
Neff et al.,  1982), anti-laminin receptor antibody to human 
breast carcinoma cells (Liotta et al.,  1985), and anti-ancho- 
rin CII receptor antibody on chicken chondrocyte membranes 
(Mollenhauer et al.,  1984) block cell attachment.  In con- 
trast, antibody to GPl:Ib/IIIa promoted detachment, but had 
no obvious effect on initial cell substrate attachment. The in- 
ability of anti-GPIIb/IIIa IgG to inhibit cell attachment to 
extracellular matrix and to fibronectin-coated surface was 
surprising because the complex in platelets binds multiple 
proteins containing RGD sequences (Gartner and Bennett, 
1985; Ginsberg et al.,  1985; Pytela et al.,  1986). The func- 
tion of endothelial GPIIb/IIIa thus appears to be different 
from that of other cell attachment proteins identified by cell 
attachment assays. 
There is no reason to believe a priori that the mechanism 
endothelial cells use to reattach initially is the same as the 
mechanism(s) they use to maintain adherence. Urushihara 
and Yamada (1986) found that two distinct molecules were 
involved in the attachment assays and in cell spreading on 
fibronectin-coated matrix.  Grinnell (1978) pointed out that 
the ability of EDTA-trypsin to detach ceils was inhibited at 
low temperature,  implying that detachment was  an active 
process that was not simply explained as the dissociation of 
a receptor and ligand. Surprisingly little is known about the 
process proposed by Grinnell, and we certainly do not know 
that the same proteins detected in cell attachment assays are 
the same as those used to maintain stable adhesions to the 
substrate in an existing cell layer. 
It is important to consider the role of cytoplasmic struc- 
tures in maintaining adherence of the endothelium to sub- 
strate. Suzuki et al.  (1986) recently described a transmem- 
brane  domain  of the  vitronectin receptor from a  human 
fibroblast cell line with similar molecular weight as the sub- 
units of platelet GPIIb/Illa. Horwitz et al. (1986) and Tam- 
kun et al. (1986) recently showed that CSAT receptor has a 
transmembrane linkage between fibronectin and actin. The 
transmembrane location of the CSAT receptor linking the 
cellular cytoskeleton to the extracellular matrix molecules 
makes likely a mechanism of action of anti-CSAT antibody 
(Neff et al.,  1982) one of altering receptor-ligand interaction 
resulting in changes of cytoskeletal structure. It remains to 
be seen how much similarity exists in structure and function 
between endothelial GPIIb/IIIa complex and  the  recently 
cloned integrin receptor (CSAT receptor) (Tamkun et al., 
1986).  Pratt and co-workers (1984) have shown that matrix 
components can affect the degree of migration and prolifera- 
tion of endothelial cells when cultured on a fibronectin vs. 
a  type I/III collagen  substrate.  One  could  speculate  that 
regenerating endothelial cells could "sense" different envi- 
ronments of extracellular matrix that would promote or in- 
hibit growth. 
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